Iv steroids for acute asthma

Short courses of systemic corticosteroids may provide important benefits in patients with exacerbations of COPD. A recent clinical trial 32 involving 271 patients in Veterans Affairs hospitals showed that steroid therapy resulted in moderate improvement of clinical outcomes, with shorter hospital stays and increases in FEV 1 . The fact that there were no significant differences between patients treated for two weeks and those treated for eight weeks justifies the use of a shorter course of corticosteroids to reduce the occurrence of adverse effects. Adverse effects can include hyperglycemia, secondary infection and behavioral changes. 33

Iv steroids for acute asthma

iv steroids for acute asthma

Media:

iv steroids for acute asthmaiv steroids for acute asthmaiv steroids for acute asthmaiv steroids for acute asthmaiv steroids for acute asthma